These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 36624289)

  • 1. Exploring pain catastrophizing and its associations with low disease activity in rheumatic inflammatory disorders.
    Wilk M; Pripp AH; Korkosz M; Haugeberg G
    Rheumatol Int; 2023 Apr; 43(4):687-694. PubMed ID: 36624289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pain catastrophizing in rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis: biopsychosocial perspective and impact on health-related quality of life.
    Wilk M; Łosińska K; Pripp AH; Korkosz M; Haugeberg G
    Rheumatol Int; 2022 Apr; 42(4):669-682. PubMed ID: 35098329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pain catastrophizing negatively impacts drug retention rate in patients with Psoriatic Arthritis and axial Spondyloarthritis: results from a 2-years perspective multicenter GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica) study.
    Currado D; Saracino F; Ruscitti P; Marino A; Pantano I; Vomero M; Berardicurti O; Pavlych V; Di Vico C; Caso F; Costa L; Tasso M; Camarda F; Misceo F; De Vincenzo F; Corrado A; Arcarese L; Rigon A; Vadacca M; Corberi E; Kun L; Trunfio F; Pilato A; Lamberti L; Cantatore FP; Perosa F; Guggino G; Scarpa R; Cipriani P; Ciccia F; Giacomelli R; Navarini L
    Arthritis Res Ther; 2024 Sep; 26(1):162. PubMed ID: 39294672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum calprotectin: a promising biomarker in rheumatoid arthritis and axial spondyloarthritis.
    Jarlborg M; Courvoisier DS; Lamacchia C; Martinez Prat L; Mahler M; Bentow C; Finckh A; Gabay C; Nissen MJ;
    Arthritis Res Ther; 2020 May; 22(1):105. PubMed ID: 32375861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Residual Disease Burden in Patients With Axial Spondyloarthritis and Psoriatic Arthritis Despite Low Disease Activity States in a Multiethnic Asian Population.
    Liu V; Fong W; Kwan YH; Leung YY
    J Rheumatol; 2021 May; 48(5):677-684. PubMed ID: 33132217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is the C-reactive protein-to-albumin ratio the most remarkable simple inflammatory marker showing active disease in patients with axial spondyloarthritis, psoriatic arthritis, and rheumatoid arthritis?
    Kaplan H; Cengiz G; Şaş S; Eldemir YÖ
    Clin Rheumatol; 2023 Nov; 42(11):2959-2969. PubMed ID: 37470884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High pain catastrophizing scores in one-fourth of patients on biotherapy for spondylarthritis or rheumatoid arthritis.
    Penhoat M; Saraux A; Le Goff B; Augereau P; Maugars Y; Berthelot JM
    Joint Bone Spine; 2014 May; 81(3):235-9. PubMed ID: 24321439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Residual symptoms and disease burden among patients with psoriatic arthritis: is a new disease activity index required?
    Kilic G; Kilic E; Nas K; Kamanlı A; Tekeoglu İ
    Rheumatol Int; 2019 Jan; 39(1):73-81. PubMed ID: 30426235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severity of fatigue in people with rheumatoid arthritis, psoriatic arthritis and spondyloarthritis - Results of a cross-sectional study.
    Pilgaard T; Hagelund L; Stallknecht SE; Jensen HH; Esbensen BA
    PLoS One; 2019; 14(6):e0218831. PubMed ID: 31251785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does gender influence outcome measures similarly in patients with spondyloarthritis? Results from the ASAS-perSpA study.
    RMD Open; ; . PubMed ID: 36096523
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.